COMMUNIQUÉS West-GlobeNewswire

Quotient Limited Announces Retirement of Paul Cowan, Chairman and Chief Executive Officer; Franz Walt Named as Interim Chief Executive Officer

26/03/2018 - 22:05

JERSEY, Channel Islands, March 26, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced the retirement of Paul Cowan as its Chairman and Chief Executive [...]

Sol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website

26/03/2018 - 22:05

NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL ), a clinical-stage dermatology company, announced today that it filed its Annual Report for 2017 on Form 20-F, containing [...]

DBV Technologies Announces Closing of Underwriters' Option to Purchase Additional Shares in Global Offering

26/03/2018 - 22:02

Montrouge, France, March 26, 2018 DBV Technologies Announces Closing of Underwriters' Option to Purchase Additional Shares in Global Offering DBV Technologies (the "Company") (Euronext: DBV - ISIN: FR0010417345 - Nasdaq [...]

DBV Technologies annonce le règlement-livraison des actions ordinaires supplémentaires au titre de l'exercice de la totalité de l'option de surallocation dans le cadre de son offre globale

26/03/2018 - 22:02

Montrouge, France, le 26 Mars (22h00 CEST), 2018 DBV Technologies annonce le règlement-livraison des actions ordinaires supplémentaires au titre de l'exercice de la totalité de l'option de surallocation dans le cadre de [...]

argenx announces Annual General Meeting of Shareholders on May 8, 2018

26/03/2018 - 22:01

March 26, 2018 Breda, the Netherlands - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]

MacroGenics Announces Proposed Public Offering of Common Stock

26/03/2018 - 22:01

ROCKVILLE, MD, March 26, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results

26/03/2018 - 22:01

TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

CRISPR Therapeutics Announces the Retirement of Tyler Dylan-Hyde and Appointment of Shelby Walker as Head of Intellectual Property

26/03/2018 - 22:01

ZUG, Switzerland and CAMBRIDGE, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]

Data From TOPACIO Trial Reported at SGO Demonstrates Compelling Clinical Activity of ZEJULA in Combination With an Anti-PD-1 Antibody in Patients With Platinum Resistant/Refractory Ovarian Cancer

26/03/2018 - 22:00

Efficacy of niraparib in combination with an anti-PD-1 mAb surpasses historical efficacy benchmarks for PD-1 or PARP monotherapies in difficult-to-treat types of ovarian cancer, regardless of biomarker status Potential [...]

Stage 3 Meaningful Use Certification Achieved by PracticeSuite EHR

26/03/2018 - 20:38

SILICON VALLEY, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Cloud based medical office platform PracticeSuite announced today it has achieved Stage 3 Meaningful Use certification of its electronic health record (EHR) [...]

Medical Cannabis Protections Extended to 46 States

26/03/2018 - 19:49

ALBUQUERQUE, New Mexico, March 26, 2018 (GLOBE NEWSWIRE) -- Medical cannabis patients and businesses are protected from federal intervention after President Trump signed the country’s new spending bill into law Friday. [...]

MJ Biotech Inc. Q & A Update w/ Doctor Interview

26/03/2018 - 19:46

CHEYENNE, Wyo., March 26, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced that the interview with Maxine Pierson CEO of MJ Biotech, Inc and Fernando Lopez COO of MJ [...]

Ossur Hf : Transactions in relation to share buyback program

26/03/2018 - 18:01

Announcement no. 23/2018 Reykjavik, 26 March 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

Physeon Reports Positive Clinical Trial Results for its Veinplicity Device

26/03/2018 - 17:29

SCHAFFHAUSEN, Switzerland, March 26, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced positive results from its [...]

Preclinical Data Showing Synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone Symposia

26/03/2018 - 16:00

EAGAN, Minn., March 26, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. and the Abramson Cancer Center of the University of Pennsylvania announced today the presentation of new preclinical data demonstrating the [...]

Puerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based Relief

26/03/2018 - 15:44

BETHESDA, Md. and SAN JUAN, Puerto Rico, March 26, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) – Alzheimer’s patients in Puerto Rico will be the first in the United States to obtain [...]

FDA approves inclusion of data on cardiovascular outcomes and severe hypoglycaemia in the Tresiba® label

26/03/2018 - 15:32

Bagsværd, Denmark, 26 March 2018 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an update to the US prescribing information for Tresiba ® (insulin degludec) to include data [...]

Millennium BlockChain Announces Major Investment in Online Broker Dealer ChoiceTrade

26/03/2018 - 15:31

Millennium BlockChain, first publicly traded company to conduct stock swaps for equity in blockchain companies, partners with ChoiceTrade to introduce the next generation of trading LAS VEGAS / SAN JUAN, PUERTO RICO, [...]

iKang Enters into Definitive Merger Agreement for Going Private Transaction

26/03/2018 - 15:25

BEIJING, March 26, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today [...]